UC Medical Center to Honor Developer of Polio Vaccine with Ohio Historical Marker
The UC Medical Center will honor the accomplishments of Albert B. Sabin, MD, with the dedication of an Ohio Historical Marker on Thursday, June 19 at 4 p.m. at the entrance to the Vontz Center for Molecular Studies, UC Medical Center. Dr. Sabin was a faculty member of the UC College of Medicine and Cincinnati Children's Hospital Research Foundation (CHRF) when he developed the live-virus polio vaccine in 1960.
The marker, sponsored by the Ohio Historical Society to celebrate the Ohio Bicentennial, will be placed in front of the Vontz Center at the corner of Martin Luther King Drive and Eden Avenue. The marker complements the permanent display of Dr. Sabin's work housed in the lobby of the Vontz Center.
To date, there are 43 Ohio Historical Markers in Hamilton County alone. The Ohio Bicentennial Commission was formed in 1995 to promote and plan for Ohio's 200th birthday in 2003. Since its inception, the Ohio Bicentennial Commission has spearheaded two programs that have generated more than 500 new historical markers in the state of Ohio.
Guests of honor at the event include Dr. Sabin's widow, Heloisa Sabin, from Washington D.C.; Jack Blosser of the Ohio Historical Society; Thomas F. Boat, MD, chair of the Department of Pediatrics at the UC College of Medicine, director of CHRF and interim provost for Health Affairs at the UC Medical Center; and William J. Martin II, MD, dean of the UC College of Medicine and acting Senior Vice President of the UC Medical Center.
Related Stories
Can new research improve the safety of AI therapy for teens?
December 5, 2025
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition for a discussion on the growing trend of young people turning to artificial intelligence for mental health support and therapy.
Student-designed AI platform aims to match patients to specific cancer support groups
December 5, 2025
The University of Cincinnati is launching a clinical trial testing a student-designed, machine-learning powered platform to match patients with cancer to support groups specifically tailored to their needs and concerns.
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.